نتایج جستجو برای: recombinant follicle

تعداد نتایج: 130969  

2014
Rogério de Barros F. Leão Sandro C. Esteves

Gonadotropin therapy plays an integral role in ovarian stimulation for infertility treatments. Efforts have been made over the last century to improve gonadotropin preparations. Undoubtedly, current gonadotropins have better quality and safety profiles as well as clinical efficacy than earlier ones. A major achievement has been introducing recombinant technology in the manufacturing processes f...

2008
Fatma A. Aletebi F. A. Aletebi

The use of progesterone for luteal support in stimulated cycles for in-vitro fertilization is well established. However, the benefits of the addition of estradiol are still controversial. The aim of this study was to compare ongoing pregnancy rates in patients stimulated with recombinant follicle stimulating hormone and gonadotrophin releasing hormone antagonist for in vitro fertilization, who ...

2016
Dae-Jung Kim Chae-Won Park Munkhzaya Byambaragchaa Shin-Kwon Kim Bae-Ik Lee Hyung-Kyu Hwang Jeong-In Myeong Sun-Mee Hong Myung-Hwa Kang Kwan-Sik Min

Monoclonal antibodies were generated against recombinant follicle-stimulating hormone (rec-FSH) from Japanese eel Anguilla japonica; rec-FSH was produced in Escherichia coli and purified using Ni-NTA Sepharose column chromatography. In support of our recent publication, "Production and characterization of monoclonal antibodies against recombinant tethered follicle-stimulating hormone from Japan...

Journal: :International journal of fertility and women's medicine 1997
I J Duijkers W N Willemsen H M Hollanders C J Hamilton C M Thomas H M Vemer

OBJECTIVE A small amount of LH is necessary for 17beta-estradiol production in the ovarian follicle. Human menopausal gonadotropin (hMG) contains equal amounts of FSH and LH activity, whereas recombinant FSH is a gonadotropin preparation without LH. The aim of the present randomized study was to investigate whether ovarian stimulation treatment with recombinant FSH or hMG resulted in different ...

Journal: :Human reproduction 2005
J N Hugues J Soussis I Calderon J Balasch R A Anderson A Romeu

BACKGROUND In anovulatory women undergoing ovulation induction, addition of recombinant human LH (rLH) to FSH treatment may promote the dominance of a leading follicle when administered in the late follicular phase. The objective of this study was to find the optimal dose of rLH that can maintain the growth of a dominant follicle, whilst causing atresia of secondary follicles. METHODS Women w...

Ahanjan M Amiri Yekta A Bahraminejad E Ebrahimi S, Eskandari Nasab MP Fatemi N Gourabi H Mirshahvaladi Sh Nekookar AB Sanati MH

Background: Bovine follicle stimulating hormone (bFSH) belongs to the family of glycoprotein hormones that are released from the pituitary gland or the placenta. This hormone is a heterodimer consisting of common α- and specific β-subunit. Bovine FSH is used for reproductive technology such as superovulation in farm animals and polycystic ovary syndrome treatment. Also this hormone is produced ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید